These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 30703387)
21. Brodalumab versus ustekinumab in psoriasis. Fioranelli M; Roccia MG; Lotti T Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075 [No Abstract] [Full Text] [Related]
22. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting. Baniandrés O; Rodríguez-Soria VJ; Romero-Jiménez RM; Suárez R Actas Dermosifiliogr; 2015 Sep; 106(7):569-77. PubMed ID: 25935194 [TBL] [Abstract][Full Text] [Related]
23. Psoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab. Raposo I; Carvalho C; Bettencourt A; Da Silva BM; Leite L; Selores M; Torres T Eur J Dermatol; 2017 Oct; 27(5):528-530. PubMed ID: 29084639 [No Abstract] [Full Text] [Related]
24. Medication adherence among patients with psoriasis on traditional systemic and biologics treatment. Hambly R; Kelly A; Gilhooley E; Nic Dhonncha E; Murad A; Hughes R; Lally A; Kirby B Br J Dermatol; 2018 Jan; 178(1):e46-e48. PubMed ID: 28762482 [No Abstract] [Full Text] [Related]
25. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy. Fujita Y; Shinkuma S; Nomura T; Shimizu H Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260 [No Abstract] [Full Text] [Related]
26. Ustekinumab for the treatment of psoriasis: an evidence update. Yiu ZZ; Warren RB Semin Cutan Med Surg; 2018 Sep; 37(3):143-147. PubMed ID: 30215630 [TBL] [Abstract][Full Text] [Related]
27. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Menter A; Strober BE; Kaplan DH; Kivelevitch D; Prater EF; Stoff B; Armstrong AW; Connor C; Cordoro KM; Davis DMR; Elewski BE; Gelfand JM; Gordon KB; Gottlieb AB; Kavanaugh A; Kiselica M; Korman NJ; Kroshinsky D; Lebwohl M; Leonardi CL; Lichten J; Lim HW; Mehta NN; Paller AS; Parra SL; Pathy AL; Rupani RN; Siegel M; Wong EB; Wu JJ; Hariharan V; Elmets CA J Am Acad Dermatol; 2019 Apr; 80(4):1029-1072. PubMed ID: 30772098 [TBL] [Abstract][Full Text] [Related]
28. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs. Tabolli S; Giannantoni P; Paradisi A; Abeni D Br J Dermatol; 2015 Jul; 173(1):256-8. PubMed ID: 25422080 [No Abstract] [Full Text] [Related]
29. Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study. Shahbaz A; Qiang J; Marinas JEC; Kim WB; Greaves S; Yeung J Br J Dermatol; 2017 Jul; 177(1):297-298. PubMed ID: 27639251 [No Abstract] [Full Text] [Related]
30. Drug survival of biologic treatments in psoriasis: a systematic review. No DJ; Inkeles MS; Amin M; Wu JJ J Dermatolog Treat; 2018 Aug; 29(5):460-466. PubMed ID: 29076754 [TBL] [Abstract][Full Text] [Related]
32. Biologic drug survival in Israeli psoriasis patients. Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of biologics in psoriasis patients under hemodialysis. Larquey M; Girard C; Sbidian E; Richard MA; Aubin F; Schmutz JL Eur J Dermatol; 2017 Oct; 27(5):531-533. PubMed ID: 28944757 [No Abstract] [Full Text] [Related]
34. Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis. Wong IT; Shojania K; Dutz J; Tsao NW Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):153-66. PubMed ID: 26681527 [TBL] [Abstract][Full Text] [Related]
35. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment. Krueger GG Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383 [No Abstract] [Full Text] [Related]
36. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment. Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153 [No Abstract] [Full Text] [Related]